NEW YORK, June 18 - DNA Sciences has changed the name of its wholly-owned subsidiary PPGx laboratories to DNA Sciences Laboratories in an effort to create vertical integration, the company said Monday.
The lab's products and services will continue to be marketed exclusively through the laboratory. The Morrisville, NC-headquartered lab also has locations in La Jolla, Calif., Cambridge, Mass., and Cambridge, UK. The labs conduct clinical genotyping, assay development and validation, target validation, allele frequency determination, and polymorphism discovery.
"Our goal is to cultivate a unified identity for DNA Sciences across the spectrum of our business activities, including clinical support services and research collaborations that seek to identify genetic variants involved in treatment response," Hugh Rienhoff, CEO of DNA Sciences, said in a statement. "In addition, DNA Sciences Laboratories enables commercialization of products resulting from our own discovery efforts. As genetics becomes integrated into the drug discovery and development process, we anticipate our clinical laboratories business to grow aggressively."DNA Sciences studies the role genes play in diseases such as cancer, asthma, and diabetes. It is also planning to commercialize diagnostic tests.